Trial Drug Could Clear Toxic Alzheimer’s Proteins and Restore Memory
A preclinical study found that a copper-containing compound restores the brain's ability to clear toxic proteins. The drug reduced amyloid buildup and improved memory and cognitive function in laboratory experiments. Because it has been tested in humans for other neurological conditions, it may be fast-tracked for treatment.
What changed
New data from Monash University provides specific percentage improvements in protein clearance and memory.
Live updates
-
Copper-Based Drug Clears Alzheimer's Proteins and Restores Memory
confidence 100%A preclinical study found that a copper-containing compound restores the brain's ability to clear toxic proteins. The drug reduced amyloid buildup and improved memory and cognitive function in laboratory experiments. Because it has been tested in humans for other neurological conditions, it may be fast-tracked for treatment.
What's confirmed:
- A copper-based compound restored the brain's ability to clear toxic Alzheimer's proteins and reduced amyloid buildup.
- Laboratory trials show the copper therapy improves cognitive function, spatial learning, and memory.
- The drug has already undergone human testing for other neurological conditions.
- The compound Cu(ATSM) increased P-gp pumps by 24% and cut amyloid-beta by 42% in Alzheimer's models.
- Spatial memory improved by 44% in Alzheimer's models using Cu(ATSM).